<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114307">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01896167</url>
  </required_header>
  <id_info>
    <org_study_id>H-4-2012-182</org_study_id>
    <nct_id>NCT01896167</nct_id>
  </id_info>
  <brief_title>Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by Hypoxia</brief_title>
  <official_title>Study of Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries by Hypoxia in a Humane Experimental Migraine Model</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danish Headache Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Danish Headache Center</source>
  <oversight_info>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <authority>Denmark: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators will investigate the following hypothesis

        -  that hypoxia induce migraine headache and migraine aura

        -  the aura phase is associated with a spreading reduction in cerebral blood flow

        -  the migraine headache is associated with dilatation of intra- and extracerebral
           arteries

        -  the pre-ictal stage of a migraine attack with aura is associated with specific patterns
           in neural activity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate migraine with aura symptoms during and after hypoxia.

      With magnetic resonance imaging the investigators will investigate changes in

        -  regional cerebral blood flow (rCBF)

        -  resting state functional connectivity

        -  circumference of the middle cerebral artery(MCA), internal carotic artery, superficial
           temporal artery, medial meningeal artery, external carotic artery
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Headache and aura</measure>
    <time_frame>24 h</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparison between hypoxia and placebo (atmospheric air)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>artery circumference</measure>
    <time_frame>Baseline, 90 and 180 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>Hypoxia induced changes in intra- and extracranial circumference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral blood flow</measure>
    <time_frame>Baseline, 90 and 180 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>Hypoxia induced changes in cerebral blood flow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting state functional connectivity</measure>
    <time_frame>Baseline and approximately 15 min post hypoxia</time_frame>
    <safety_issue>No</safety_issue>
    <description>To identify specific patterns in resting state functional connectivity (RSFC) in the pre-ictal stage of a migraine attack induced by hypoxia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Headache</condition>
  <condition>Migraine</condition>
  <condition>Aura</condition>
  <arm_group>
    <arm_group_label>Hypoxia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Inhalation of air with 8-12% oxygen content</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Atmospheric air</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Inhalation of atmospheric air, with oxygen content at 21%</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypoxia</intervention_name>
    <description>Inhalation of hypoxic air (8-12% oxygen content)</description>
    <arm_group_label>Hypoxia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Inhalation of atmospheric air</description>
    <arm_group_label>Atmospheric air</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Migraine with aura patients

          -  Aged 18-40

          -  50-100 kg

        Exclusion Criteria:

          -  Tension type headache more than 5 days/month

          -  Other primary headaches

          -  Daily medication except contraceptives

          -  Drug taken within 4 times the halflife for the specific drug except contraceptives

          -  Pregnant or lactating women

          -  Headache or migraine attack within the last 48 hours before start of trial

          -  Hypertension

          -  Hypotension

          -  Respiratory or cardiac disease

          -  smoking
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nanna Arngrim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology, Glostrup Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nanna Arngrim, MD</last_name>
    <phone>004538634612</phone>
    <email>nanna.bjoerkbom.arngrim.01@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nanna Arngrim</name>
      <address>
        <city>Glostrup</city>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nanna Arngrim, MD</last_name>
      <phone>00 45 38 63 46 12</phone>
      <email>nanna.bjoerkbom.arngrim.01@regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Nanna Arngrim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 10, 2013</lastchanged_date>
  <firstreceived_date>June 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Danish Headache Center</investigator_affiliation>
    <investigator_full_name>Nanna Arngrim</investigator_full_name>
    <investigator_title>MD, medical doctors</investigator_title>
  </responsible_party>
  <keyword>Headache</keyword>
  <keyword>Migraine</keyword>
  <keyword>Aura</keyword>
  <keyword>Cerebral hemodynamics</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Migraine with Aura</mesh_term>
    <mesh_term>Anoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
